Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Comprehensive cDNA study and quantitative transcript analysis of mutant OPA1 transcripts containing premature

Simone Schimpf1, Nico Fuhrmann, Simone Schaich

  • 1Molecular Genetics Laboratory, University Eye Hospital, Tuebingen, Germany. Simone.Schimpf@uni-tuebingen.de

Human Mutation
|August 28, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical manifestations of dual-gene variants in retinitis pigmentosa.

Acta ophthalmologica·2026
Same author

Blood mtDNA markers of mitochondrial subtype and early-onset Parkinson's disease biology.

Brain : a journal of neurology·2026
Same author

Identification of Brimonidine as a Novel Substrate of Organic Cation Transporters OCT2 and MATE1 Expressed in Human Eye.

Investigative ophthalmology & visual science·2026
Same author

SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutions.

American journal of human genetics·2026
Same author

De novo and inherited dominant variants in U4 and U6 snRNA genes cause retinitis pigmentosa.

Nature genetics·2026
Same author

Safety and vision outcomes of subretinal gene supplementation therapy in <i>PDE6A</i>-associated retinitis pigmentosa: a non-randomised controlled trial.

The British journal of ophthalmology·2025
Same journal

Single-Cell and Multiomics Characterization of p21 in Cancer Progression and Therapeutic Sensitivity.

Human mutation·2026
Same journal

COL1A1 and SERPINE1 as Potential Therapeutic Targets in Diabetic Retinopathy: A Study Incorporating RNA Transcriptomics, Single-Cell RNA Sequencing, and Proteomics.

Human mutation·2026
Same journal

Autosomal Dominant Missense <i>DAG1</i> Variant Linked to Mild-Moderate LGMD R16.

Human mutation·2026
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
See all related articles

Autosomal dominant optic atrophy (adOA) is primarily caused by OPA1 gene mutations. cDNA analysis reveals splice defects and nonsense-mediated mRNA decay, supporting haploinsufficiency as the main disease mechanism.

Area of Science:

  • Genetics
  • Molecular Biology
  • Ophthalmology

Background:

  • Autosomal dominant optic atrophy (adOA) is a common inherited optic neuropathy.
  • Mutations in the OPA1 gene are the primary cause of adOA.
  • Previous studies primarily focused on genomic DNA analysis of OPA1 mutations.

Purpose of the Study:

  • To identify and characterize novel OPA1 mutations at the cDNA level.
  • To investigate the impact of OPA1 mutations on mRNA splicing and stability.
  • To elucidate the pathomechanism underlying OPA1-associated adOA.

Main Methods:

  • Identification and analysis of 22 novel and 15 known OPA1 mutations at the cDNA level.
  • Splicing defect analysis, including exon skipping and cryptic splice site activation.

Related Experiment Videos

  • Allele-specific quantification of mutant transcript levels using pyrosequencing and RT-PCR.

    • Main Results:

    • 18 of the analyzed OPA1 mutations caused splice defects.
    • A reduced level of mutant OPA1 transcripts was observed in adOA subjects.
    • The majority of OPA1 mutations leading to a premature termination codon (PTC) undergo nonsense-mediated mRNA decay (NMD), with transcript reduction between 1.25- and 2.5-fold.

    Conclusions:

    • cDNA analysis is crucial for comprehensive characterization of OPA1 mutations.
    • Nonsense-mediated mRNA decay plays a significant role in OPA1-associated adOA.
    • Haploinsufficiency is a major pathomechanism in OPA1-related autosomal dominant optic atrophy.